Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JP9Y | ISIN: DK0060336014 | Ticker-Symbol: NZM2
Tradegate
17.05.24
20:27 Uhr
58,14 Euro
-0,28
-0,48 %
1-Jahres-Chart
NOVONESIS A/S Chart 1 Jahr
5-Tage-Chart
NOVONESIS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
58,1458,6007:12
58,2658,5817.05.

Aktuelle News zur NOVONESIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrNovozymes A/S: Trading by management and close relations of management4
08.05.Novozymes A/S: Trading by management and close relations of management8
04.05.Earnings call: Novozymes maintains steady outlook amid modest growth15
03.05.Novozymes A/S: Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration360For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA...
► Artikel lesen
03.05.Novozymes A/S: Trading statement Q1 2024148Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook. Ester Baiget, President & CEO: "I am pleased with the first quarter organic sales growth of 4% with...
► Artikel lesen
01.05.Dividendenbekanntmachungen (01.05.2024)4.834 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  BALOISE HOLDING AG ADR  US0587791098  0,4983 USD  0,467 EUR  CANADIAN UTILITIES LIMITED  CA1367178326  0,453 CAD  0,3082 EUR  DANONE SA...
► Artikel lesen
30.04.Novozymes A/S: Resolutions from the annual shareholders' meeting 2024242Today an ordinary shareholders' meeting was conducted. The following resolutions were made:• Approval of the audited Annual Report for 2023• Approval of distribution of profit with payment of an...
► Artikel lesen
08.04.Novozymes A/S: Invitation to the annual shareholders' meeting476
08.04.Novozymes A/S: Share-based legacy RSU program granted292
27.03.NASDAQ OMX Nordic: Change of name and ticker code for Novozymes (97/24)270The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024 approved a secondary name of the company Novonesis A/S. As a consequence of the name change, Novozymes has...
► Artikel lesen
22.03.Novonesis showcased mood support probiotic at Expo West: MindAble 1714 targets gut-brain axis16
21.03.Novozymes A/S: 2024 outlook and pro forma financials50
18.03.Novozymes A/S: Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 2116
18.03.Biotalys NV: Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG477Press release - inside information Biotalys and Novonesis have entered into an agreement to advance EVOCA NG - the next generation of Biotalys' product candidate EVOCA* - to the final stage of development.Pending...
► Artikel lesen
12.03.FMC Canada to distribute Novonesis biosolutions in 202520
08.03.NASDAQ OMX Nordic: Anticipated change of name and ticker code for Novozymes (67/24)459The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024, approved a secondary name of the company Novonesis A/S. As a consequence, Novozymes has changed its stock...
► Artikel lesen
05.03.Nasdaq Copenhagen A/S: Novozymes A/S - change of share name to Novonesis (Novozymes)B353The changes below will take effect on Nasdaq Copenhagen as per 6 March 2024. ISIN: DK0060336014 ------------------------------------------------ Name Novozymes B ...
► Artikel lesen
04.03.Novozymes A/S: Resolutions from the Extraordinary Shareholders' Meeting 2024303Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders' meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and amendment...
► Artikel lesen
09.02.Invitation to an extraordinary shareholders' meeting of Novozymes A/S30
02.02.Novonesis emerges from Chr. Hansen-Novozymes merger: The new company offers enzymes, microbial technologies and ingredients44
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1